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Weight Suppression as a Predictor Variable in the Treatment of Eating Disorders: A 
Systematic Review 
Running head: WEIGHT SUPPRESSION IN EATING DISORDERS 
 
Abstract 
Introduction: Weight suppression (WS – the difference between highest body weight and 
current body weight) has been proposed as a predictor of treatment outcome within eating 
disorders (EDs), although this hypothesis has not been consistently supported. 
Aim/Question: Review the association between pre-treatment WS and outcome following 
psychological treatment for EDs. Method: A comprehensive electronic database search for 
published and unpublished literature from 1979 to 2017.  Reference lists were also inspected.  
Eligibility criteria were determined according to relevant guidelines and a quality appraisal 
was conducted. Results: Twelve studies met inclusion criteria (one was subsequently 
excluded based on insufficient data). Greater WS was generally associated with weight gain 
at post-treatment although not with other treatment outcomes. Discussion: The existing 
evidence, with data from 1566 participants, is summarised according to three main post-
treatment outcomes: weight change; treatment completion; and symptom abstinence.  Patients 
with disordered eating and greater WS may need to gain more weight than others during 
treatment to achieve good outcomes.  Recommendations for future studies are provided. 
Implications for Practice: Evidence-based treatments for EDs may benefit from considering 
WS when planning treatment, such as further psychoeducation on weight changes. Societal 
interventions regarding promotion of healthy eating may also draw on these findings. 
 
Keywords: eating disorders, weight suppression, treatment outcome, CBT  
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Relevance Statement 
We believe that this review paper can help inform mental health professionals who work 
directly with eating disorders, particularly those providing psychological interventions, such 
as CBT.  The results of the study help to clarify the role of weight suppression as a predictor 
of outcome in treatment, and support calls for the provision of additional support (e.g., 
psychoeducation) for patients high in weight suppression.  Discouragement of strict dieting 
as a public health intervention might also be considered. 
 
Accessible Summary: 
What is known on the subject? 
- Weight suppression (WS) has been suggested to predict outcome following 
psychological treatment for an eating disorder (ED) 
- Some findings are contradictory and have not been considered systematically 
What the paper adds to existing knowledge: 
- The review suggests that weight gain at post-treatment is reliably predicted by pre-
treatment WS, but findings regarding other outcomes (e.g., treatment drop-out) are less 
consistent 
- Approximate effect sizes for observed relationships are identified, alongside support for 
biobehavioural theories of metabolic adaptation to weight loss 
What are the implications for practice? 
- Degree of WS at pre-treatment is associated with weight gain and is important for 
clinicians to consider before offering treatment to patients with EDs 
- Patients high in WS might benefit from further support (e.g., psychoeducation) prior to 
beginning treatment 
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Introduction 
Whilst significant progress has been made in refining and evaluating psychological 
treatments for eating disorders (EDs), less is known about factors that are associated with 
better outcome (Cooper et al., 2016).  Weight suppression (WS) is a variable that may 
represent one such predictor (Butryn, Lowe, Safer, & Agras, 2006).  Relative WS, defined as 
one’s highest ever body weight minus current body weight, is a metric that is easy to 
calculate and may serve as a useful prognostic factor with importance in treatment decision-
making and recommendations.  However, its utility in this regard has been called into 
question given failure to confirm this finding in a number of samples (e.g., Dawkins, Watson, 
Egan, & Kane, 2013).   
A review by Keel (2010) suggested that prognostic factors in anorexia nervosa (AN) 
might include severity and duration of illness, whereas psychiatric comorbidity and general 
psychiatric severity may be more important in bulimia nervosa (BN).  Few reliable predictors 
of outcome have been found for binge-eating disorder (BED), but may include baseline 
psychopathology (such as frequency of binge eating and body dissatisfaction; e.g., Lammers, 
Vroling, Ouwens, Engels, & van Strien, 2015).  However, WS is a feature that might 
represent an important prognostic indicator that is applicable transdiagnostically.  Higher WS 
has been associated with maintenance of bulimic symptoms over time (e.g., Keel & 
Heatherton, 2010) and may also affect levels of serum hormones, such as leptin, that are 
associated with food intake and satiation (e.g., Keel, Bodell, Haedt-Matt, Williams, & 
Appelbaum, 2017). 
It has been theorised that individuals with EDs who report long-term energy 
imbalance such that their weight is below what would be expected given their weight history 
(i.e., those high in WS) are caught in a biobehavioural, or psychobiological, “bind” (e.g., 
Butryn et al., 2006); suppressing weight may reduce some of the distress associated with an 
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ED (e.g., improving body image) but concomitantly drive binge eating and compensatory 
behaviours, including further dieting.  Systemic adaptations that result from maintaining a 
reduced body weight (e.g., alterations in neuronal activity, hormone changes) have been 
proposed as an underlying mechanism involved in the difficulty sustaining low weight, 
whereby a weight-reduced state favours energy conservation and increased dietary intake 
(Rosenbaum, Kissileff, Mayer, Hirsch, & Leibel, 2010).  In partial support of this, Stice, 
Durant, Burger, and Schoeller (2011) found that greater WS predicted future increases in 
BMI, although reduced resting metabolic rate did not seem to determine the strength of the 
relationship between WS and BMI. 
Rationale for the review 
While there has been some evidence in support of the biobehavioural bind theory in EDs 
(e.g., see Keel & Heatherton, 2010), the usefulness of WS specifically as a predictor of 
treatment outcome has been questioned, given failure to replicate many findings related to 
treatment outcome (e.g., Carter, McIntosh, Joyce, & Bulik, 2008; Dawkins et al., 2013; 
Zunker et al., 2011).  Given observed inconsistencies, confidence in the predictive role of WS 
cannot be held without question and there is therefore a gap in our knowledge regarding the 
relationship between WS and treatment outcome. 
Aims 
There have been no systematic reviews of the literature on the predictive ability of WS in ED 
treatment outcome and, therefore, it is important to assess commonalities and differences 
across studies in a systematic way that aims to cover the breadth of current literature.  A 
review would provide a summary of the existing state of the evidence regarding WS, 
enabling reliable and accurate conclusions to be drawn, thereby informing refinement and 
delivery of psychological treatments. 
Objective 
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To conduct a systematic review that looks at the extent to which WS predicts outcome 
following treatment for EDs.  As such, the review will cover treatment studies, but will 
exclude studies looking at, for example, maintenance of the illness without explicit delivery 
of treatment. 
Review question 
Review question: Does pre-treatment (baseline) WS predict outcome following psychological 
treatment for EDs? 
Method 
A systematic review was conducted, guided by the recommendations of PRISMA 
(Moher et al., 2009) and with reference to PICOS criteria for defining a research question.  
The review protocol has been registered in the PROSPERO International Prospective 
Register of Systematic Reviews (Removed for blind review). 
Meta-analysis was considered but not completed for a number of reasons.  Sample 
sizes were variable (range = 35 – 350) and reported measures of effect size varied across 
studies, making it impossible to derive a consistent metric without markedly sacrificing 
power.  Typically, either odds ratios or regression equations were reported (sometimes, both).  
Although it is possible to obtain a measure of effect size from dichotomised outcomes (e.g., 
Sánchez-Meca, Marín-Martínez, & Chacón-Moscoso, 2003), it was unclear from some 
studies whether standardised or unstandardized regression coefficients were reported and 
repeated imputation would have risked excessive ‘second-order sampling error’ (e.g., Hunter 
& Schmidt, 1990).  Included articles were therefore analysed thematically, generating 
suggestions for reporting further studies in this area. 
Study identification 
Regarding ‘Study Design’, studies of relevant groups (i.e., excluding individual case 
studies) were considered for inclusion.  Attempts were made to include studies not in the 
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‘published’ domain (e.g., grey databases, studies in progress).  We conducted a literature 
search using electronic databases (Scopus, OVID, PsycINFO, PubMed [including 
MEDLINE], Google Scholar) without language restriction covering the period January 1979–
November 2017.  Grey literature searches included ClinicalTrials.gov and the ISRCTN 
Register.  Vocabulary terms (MeSH) were used with the keywords of ‘weight suppression’ 
and ‘eating disorders’, using wildcards where necessary.  To increase range, additional 
searches substituted ‘eating disorders’ with ‘anorexia nervosa’, ‘bulimia nervosa’, and 
‘binge’ (again, using wildcards).  Reference lists of included articles and others relevant to 
the topic were also manually searched.  Based on this methodology, unmasked reports were 
used.  Shortly after the search was completed, we became aware of one further article 
(Hessler et al., 2017) that would have met inclusion criteria.  This was therefore included in 
the review. 
Data collation and extraction 
Two investigators (Identifiers removed for blind review) independently screened titles 
and abstracts and selected full texts for inclusion in the review, using a standardised template 
based on the Data Collection Form of Cochrane Reviews.  Any disagreements were resolved 
by consensus, or through involvement of a third reviewer (Removed) and reasons for 
exclusion of full-texts were recorded.  Where more information was required, an attempt was 
made to contact corresponding authors.  Risk of bias was assessed to appraise the strength of 
the evidence reviewed (CRD, 2008).  In the current study, the Newcastle-Ottawa Scale (NOS; 
Wells et al., 1999) formed a basis for assessment of the likelihood of bias; a star system is 
used such that studies can be graded on criteria relating to study design, including selection of 
cohorts (maximum of four stars), comparability of cohorts (maximum of one star), and 
assessment of outcome (maximum of three stars).  The NOS is reviewer-rated and has been 
recommended by the Cochrane Non-Randomised Studies Methods Group (Reeves et al., 
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2011) for use with non-randomised studies.  The NOS was modified in our study to more 
accurately fit the review question and was ‘scored’ from zero to eight, with a score of eight 
representing the least amount of bias.  As all studies reported WS at baseline, Item 4 
(Demonstration that outcome of interest was present at the start of the study) was replaced by 
an item assessing reference to statistical power (Adequate reporting of statistical power).  
Item 8 (Adequacy of follow-up) was not included as this review focused on end-of-treatment 
data only.  Due to critiques of the use of summary scores to determine quality / risk of bias 
(e.g., Stang, 2010), a combination of qualitative and quantitative assessment is reported. 
Eligibility criteria 
Eligible studies included any treatment study (‘Intervention’) published in a peer-
reviewed journal and written in English that looked at pre-treatment (baseline) WS as a 
predictor of outcome following treatment for EDs, diagnosed according to formal criteria 
(‘Outcome’).  Potential outcomes included measures of ED psychopathology, behavioural 
symptoms, treatment adherence, and weight change.  Studies that met other criteria but did 
not explicitly look at WS were not included or their authors contacted for more information.  
Samples comprised of adolescents and adults (‘Population’) assessed before and after 
treatment (‘Comparison’) were included.  No age limits were set, although no studies 
included participants below 12 years of age and the upper age reported in the studies was 65 
years. 
Study selection 
Outputs from all databases were combined and duplicates removed.  Articles meeting 
inclusion criteria were then reviewed and screened for inclusion in meta-analysis (i.e., 
whether a suitable effect size could be derived).  Relevant data extracted from articles 
included: sample size and setting; demographics (e.g., gender, age, ethnicity); BMI; 
diagnostic breakdown; treatment type (e.g., CBT); duration of treatment (including number of 
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sessions); length of follow-up (where given); outcome (i.e., weight change, symptom 
abstinence, treatment completion); results used for calculation of effect sizes.  We also 
looked at how WS was computed and how weight and height were obtained. 
Data synthesis 
Findings are synthesised in a narrative review, with summary tables to aid 
comparisons.  The predictive ability of WS was evaluated relating to different outcomes 
(weight change, treatment completion, symptom abstinence) following treatment.  The term 
‘weight change’ is used to refer to the spectrum of weight change rather than weight gain 
specifically, although these terms have been used synonymously (e.g., Carter et al., 2008).  A 
number of studies also reported outcomes relating to rate of weight change, but this 
invariably showed near-perfect correlation with weight change and therefore resulted in 
similar findings (e.g., Carter et al., 2015; Wildes & Marcus, 2012): we therefore chose not to 
report this as a separate outcome variable. 
Weight change was treated as a continuous variable (although Carter et al. [2008] also 
considered an arbitrary division of weight change ±5kg), and treatment completion as binary.  
Reporting of behavioural outcomes was more variable; some studies reported both 
dimensional and categorical outcomes. 
Results 
Search results 
The search, conducted in November 2017, identified 443 unique records (see Figure 
1).  Thirty-four full-text articles were reviewed, of which twelve met inclusion criteria.  One 
published article (Zunker et al., 2011) included two separate studies – one on BED and one 
on BN.  A further study (Striegel-Moore et al., 2010) concluded that WS was not a significant 
predictor of outcome within a CBT-based treatment of binge eating but did not provide more 
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detailed information.  This study was therefore excluded from the review.  Agreement 
between raters was high (kappa = 0.87, lower 95% CI = 0.70). 
Summary of studies and risk of bias 
Table 1 summarises study characteristics; all were cohort studies and deemed to be at 
moderate risk of bias (Wells et al., 1999).  The modified-NOS score (max. = 8) ranged from 2 
– 5 (see Supplementary Material, Table S1).  In all studies, WS was the primary variable of 
interest and comprised analysis of either an existing randomised study (Butryn et al., 2006; 
Carter et al., 2008; Carter et al., 2015; Zunker et al., 2011) or routinely-collected clinic data 
(Berner et al., 2013; Dawkins et al., 2013; Hessler et al., 2017; Lowe et al., 2006; 
Seetharaman et al., 2017; Wildes & Marcus, 2012).  All but one study used DSM criteria to 
define groups (Hessler et al. used ICD criteria), although different versions of the manual 
were used (ranging from DSM-III-R [APA, 1987] to DSM-IV-TR [APA, 2000]). 
[Insert Table 1] 
The eleven studies included in the narrative review reported baseline data for 1903 
participants (1864 female).  Data relating to WS as a predictor of outcome were available for 
1566 individuals.  Pre-treatment BMI varied from 9.39 – 72.6kg/m2, although not all studies 
reported minima and maxima. 
Regarding calculation of WS, current weight was recorded either by clinicians or the 
research team and, where reported, in ‘street clothing’ (e.g., Lowe et al., 2006) or a hospital 
gown (e.g., Wildes & Marcus, 2012).  Precise definition of highest weight varied slightly, 
with some studies explicitly stating that highest ever weight was used (Butryn et al., 2006) 
and others specifying highest adult weight (e.g., Zunker et al., 2011) or highest lifetime non-
pregnancy weight at adult height (Berner et al., 2013).  Participants were usually asked to 
recall their highest weight (either in clinical interview or via self-report).  Assessment of 
eating pathology employed standardised measures with good psychometric properties; these 
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differed across studies, and thus the definition of “abstinence” – where assessed – varied (see 
Table 1).  All studies used regression analyses to determine the predictive effect(s) of WS, 
except for Hessler et al. (2017) who grouped a sample of female inpatients with BN by 
degree of WS (0 – 4kg, 4 – 9kg, 9 – 15.7kg, and 15.8kg+) and compared groups via analysis 
of variance (ANOVA). 
Duration of treatment 
A range of outpatient and more intensive treatments were included (see Table 1).  The 
CBT-based (outpatient) interventions were of similar length, with mean duration ranging 
from around eight weeks (Carter et al., 2008) to 19 weeks (Dawkins et al., 2013) for 
treatment completers.  Inpatient treatment lasted considerably shorter, an average of 17.2 
days for ‘normal’-weight (Lowe et al., 2006) and around 40 days for underweight samples 
(Berner et al., 2013; Wildes & Marcus, 2012).  Hessler et al. (2017) reported a mean length of 
stay of 77.8 days for their sample of females with BN. 
Weight status 
The majority of studies included groups comprising more than one diagnosis and 
according to different versions of diagnostic manuals.  Therefore, for the purposes of this 
review, studies were classified according to inclusion of predominantly underweight or non-
underweight samples (see Table 1). 
Relationship between Weight Suppression and outcomes 
It is important to comment briefly that around half of the included studies addressed 
WS as a moderator (Berner et al., 2013; Dawkins et al., 2013; Hessler et al., 2017; Lowe et 
al., 2006).  According to Kraemer et al. (2002), moderation is defined as the presence of an 
interaction between the proposed moderator (in this case, WS) and treatment outcome.  Most 
studies looked at WS as a nonspecific predictor of outcome – i.e., a variable that has a main 
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effect on outcome but not an interactive effect (although interactive effects with treatment 
were often not reported). 
Three main outcomes were identified at post-treatment: weight change; treatment 
adherence / completion; and abstinence from binge eating / purging.  Not all studies looked at 
all variables, and results regarding individual outcomes will be discussed in turn. 
Weight change 
Greater WS was associated with greater weight gain at post-treatment, with six 
studies finding that WS independently accounted for between 1.0% (Wildes & Marcus, 2012) 
and 12.3% (Carter et al., 2015) of the variance in weight gain.  Two studies failing to find a 
predictive effect of WS were both reported by Zunker et al. (2011).  Although the sample size 
is small, there were no clear associations with weight status or diagnosis; of those studies 
finding a relationship, three included underweight samples (Berner et al., 2013; Carter et al., 
2015; Wildes & Marcus, 2012) and three included non-underweight samples (Carter et al., 
2008; Hessler et al., 2017; Lowe et al., 2006).  A chi-square test confirmed no association 
between weight status and outcome (χ2(1) = 1.806, p = .179). 
Treatment completion 
This was specified in seven studies, only one of which found that completion was 
significantly associated with pre-treatment WS.  Butryn et al. (2006) found that WS 
accounted for 22% of the variance in treatment completion and that for each increase of 1kg 
of weight suppression, odds of not completing treatment are “multiplied by a factor of 0.69” 
(p. 64).  Completion was defined according to slightly different criteria across studies; some 
reports defined completion according to number of sessions attended (e.g., Carter et al., 
2008), and others specifically described “nonmutual premature termination of treatment” 
(Dawkins et al., 2013, p. 589). 
Abstinence 
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Studies also assessed abstinence from ED behaviours at post-treatment, specifically 
binge eating and purging (usually self-induced vomiting).  The results were broadly 
consistent with those regarding treatment completion, with eight studies reporting this as an 
outcome and two (Butryn et al., 2006; Wildes & Marcus, 2012) finding that higher WS at 
pre-treatment predicted a lower likelihood of abstinence from binge eating and purging at 
post-treatment.  Presence of ED behaviours was assessed in different ways, with most studies 
using data from the Eating Disorder Examination interview (EDE; Fairburn & Cooper, 1993) 
and others employing the self-report version (EDE-Q; Fairburn & Beglin, 1994), both of 
which assess behaviours over the past four weeks.  Carter et al. (2008) used a structured 
interview which, although similar to the EDE, assessed behaviours over the previous two 
weeks and Lowe et al. (2006) used a different self-report questionnaire, the BULIT-R 
(Thelen, Farmer, Wonderlich, & Smith, 1991). 
Return of Menses 
One study (Seetharaman et al., 2017) examined WS as a predictor of return of menses 
in a transdiagnostic sample of 163 adolescents treated at an academic ED program.  The 
authors found that, in those not previously overweight (n = 33), the odds of menses returning 
decreased by 10% for every 1kg of weight suppression.  No other studies were identified in 
this review as addressing this outcome. 
Methodology of included studies 
Across studies, calculation of WS generally referred to ‘adult’ or ‘current’ height, 
either through self-report or recall during an interview.  Similarly, ED symptoms (and thus 
abstinence) were assessed by semi-structured interview (k = 6) or self-report (k = 3).  In two 
studies (Hessler et al., 2017; Seetharaman et al., 2017), psychometric measures were not 
reported.  Most studies reported on secondary analysis of existing data (e.g., from a RCT), 
and thus recruitment strategies also varied. 
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No studies found that greater WS significantly predicted better outcomes (such as 
increased likelihood of treatment completion), although some failed to find hypothesised 
associations.  It was only possible to evaluate some variables in categorical form (e.g., 
treatment completion) and thus relationships were typically examined using logistic 
regression.  Where both categorical (e.g., abstinent / non-abstinent) and continuous (e.g., 
frequency of binge eating and purging) outcomes were possible, individual studies found 
consistent results across methods (e.g., logistic and linear regression). 
Discussion 
A number of authors have looked at the ability of pre-treatment WS – defined as the 
difference between highest past weight and current weight – to predict outcome following 
treatment of EDs.  The current review describes an extensive search of existing literature to 
test this hypothesis.  Greater WS was associated with greater total weight gain at post-
treatment although this finding was not replicated in all studies.  Findings lend support to the 
theory that individuals “highest in weight suppression [are] most susceptible to future weight 
gain” (Butryn et al., 2006, p. 63), consistent with theories on metabolic adaptation and energy 
intake (e.g., see Rosenbaum et al., 2010).  However, little support was found for the 
association between WS and treatment outcomes other than weight gain. 
Evidence of the association between WS and weight change was seen in samples 
comprising both underweight and non-underweight samples, although it is possible that WS 
may have different effects across different ED diagnoses.  Of note, only one study (Zunker et 
al., 2011) looked at a sample with BED, and found no associations.  Further studies might 
examine WS in BED in greater detail.  Individuals with BED tend to report higher maximum 
weight than controls but also greater weight cycling (e.g., Borges, Jorge, Morgan, de Silveira, 
& Custódio, 2002).  In the treatment of AN, for example, weight regain is often a treatment 
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target, whereas weight change in other diagnostic groups may not necessarily be a goal of 
treatment. 
Regarding psychological and other behavioural outcomes, evidence is less conclusive.  
Of seven studies reporting data, only two (Butryn et al., 2006; Wildes & Marcus, 2012) found 
that WS predicted either treatment completion or abstinence from binge eating and vomiting 
(and in one of these [Wildes & Marcus, 2012], only abstinence).   
Studies reporting significant associations between WS and outcomes of interest 
tended to cite higher average WS at baseline, suggesting that WS may need to reach a certain 
degree to significantly impact treatment outcome (e.g., see Hessler et al., 2017).  It was not 
possible to test this hypothesis in the current review, but one recommendation is that future 
studies consider that WS may have a non-linear relationship with outcome. 
Where significant associations between WS and outcomes were found, these 
remained when covariates were considered (e.g., Butryn et al., 2006; Lowe et al., 2006).  One 
study included only adolescents (Seetharaman et al., 2017), with a number looking at mixed 
adolescent/adult samples.  It may not be possible to describe WS in adolescents who may not 
have achieved their highest adult weight, although it has been suggested that BMI z-scores 
may be more appropriate as a metric among youth (Accurso et al., 2016). 
Long-term follow-up was not a focus of this review, although there is some limited 
evidence that WS can predict longer-term outcomes.  Two studies have looked at the 
predictive significance of WS in cohorts followed for up to five (Herzog et al., 2010) or ten 
years (Keel & Heatherton, 2010), finding that WS predicts maintenance of symptoms of BN 
over time.  Keel and Heatherton (2010) also found that greater WS at baseline in those 
without an ED predicted onset of a bulimic syndrome at follow-up.  Bodell, Racine, and 
Wildes (2016) looked at degree of WS at post-treatment and found that it acted as both a 
predictor and moderator of BMI change over time which, together with findings from a 
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recent study of adolescents (Swenne, Parling, & Salonen Ros, 2017), suggests that the effects 
reported here regarding WS on weight change may endure over time. 
As noted above, a minority of studies considered whether WS has a moderator role.  
Lowe et al. (2006) examined pre-treatment WS and BMI, but failed to find evidence of a 
significant interaction, and Dawkins et al. (2013) also failed to find interactions between WS 
and pre-treatment BMI, parental history of overweight, self-reported childhood body shape, 
or the difference between highest and lowest ever adult weight.  By contrast, two studies 
(Berner et al., 2013; Hessler et al., 2017) reported a significant interaction effect between WS 
and BMI when predicting weight change, suggesting that the association between BMI and 
weight change over treatment may depend to some extent on degree of WS.  In a study not 
included in the current review, Bodell et al. (2016) looked at WS taken at post-treatment in a 
sample of females with AN and found that, not only was change in BMI over the year 
following treatment predicted, but that the interaction between WS and BMI predicted 
change in ED severity and purging frequency over the same period.  Therefore, it is possible 
that effects of WS on psychological symptoms are not evident immediately following 
treatment, but begin to emerge over time, and that interaction with BMI is of principal 
relevance for those with underweight EDs. 
The review identified twelve eligible studies, although sufficient data for review were 
not available from one of these (which concluded that there was not a significant predictive 
effect of WS on treatment outcome; Striegel-Moore et al., 2010).  Cohort designs were the 
singular means of study and the overall risk of bias was moderate, although a modified scale 
was used to suit the needs of the review.  As such, the criteria used to grade risk of bias were 
not standardised and may have represented overly strict scoring metrics.  In the studies 
reviewed, CBT was the most common treatment, although there was some variability across 
approaches.  Individual differences in WS may determine the effects of different treatments, 
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and this is one reason we advocate explicitly looking at the possible moderating effect of WS 
in addition to its predictive effect (see Kraemer et al., 2002).  Further work is required to look 
at the role of gender in more detail; although men typically comprise around 1 in 10 cases of 
EDs (which may even be an underestimate), the number of included males in this review was 
only around 2%. 
Strengths and limitations 
The strengths of this review include adherence to best practice guidelines for the 
conduct of systematic reviews and evaluation of study design and risk of bias.  Attempts were 
also made to contact corresponding authors to clarify information that was not clearly 
reported.  A limitation lies in the designs of included studies (typically cohort designs and/or 
secondary analysis of data) and that data were insufficient for meta-analysis.  Due to 
methodological constraints unmasked reviews were conducted, which may have increased the 
likelihood of bias (Jadad et al., 1998).  Although a scale was used to evaluate risk of bias 
(Wells et al., 1999), adjustments were made to its content and many of the remaining items 
did not deal well with the designs under review; thus, the scores obtained lack external 
consistency (but might retain internal consistency).  Generalisability of findings was limited 
in some respects (e.g., gender), but sampled different populations, and often analysis was of 
multi-site trials, which may have reduced selection bias.  Furthermore, the review also 
considered all ED diagnoses and is therefore applicable ‘transdiagnostically’. 
Implications and Recommendations 
The studies reviewed are relevant to clinical practice as all focused on how WS at pre-
treatment might predict response to treatment.  As stated above, the evidence does not 
conclusively support the hypothesis that higher WS is associated with better outcome 
following treatment, but it does seem to be associated with weight change.  As a result, it 
seems that some patients (i.e., those with high WS) may need to gain more weight during 
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treatment to achieve good outcomes, including normalisation of eating (Lowe et al., 2006).  
Although meta-analysis was not possible, combining results from six studies (Berner et al., 
2013; Carter et al., 2008; Carter et al., 2015; Hessler et al., 2017; Lowe et al., 2006; Wildes 
& Marcus, 2012) suggests that around 5% of the variance in weight gain is accounted for by 
pre-treatment WS (weighted mean estimate; Hunter & Schmidt, 1990).  Further research 
studies might consider this in planning stages, for example when determining sample sizes 
based on power analysis or considering a number of predictors of outcome.    
Addressing WS has not been routinely described in evidence-based treatments for 
EDs, and one group has recently suggested that this be included as part of current CBT 
models and that treatment might be augmented by addressing WS directly (Juarascio et al., 
2018).  The evidence summarised here provides indirect support for psychoeducation around 
weight gain, preparing patients for the possibility of weight gain, discussing possible weight 
fluctuations during treatment, helping patients set realistic weight goals, focusing on health 
rather than weight, and working on healthy weight management strategies (see Bulik, 
Marcus, Zerwas, Levine, & La Via, 2012; Juarascio et al., 2018).  Although psychoeducation 
is likely to confer some health benefits, a societal approach to reducing weight stigma and 
promoting healthy eating (e.g., see Paxton, Wertheim, Pilawski, Durkin, & Holt, 2002) may 
be necessary to effect lasting and widespread changes, similar to approaches used in the 
fields of diabetes and obesity (e.g., Glasgow et al., 1999; Lipek, Igel, Gausche, Kiess, & 
Grande, 2015).  Such interventions might include reference, at both the individual and 
environmental level, to the difficulty and costs of sustaining reduced body weight (e.g., 
Rosenbaum et al., 2010); this might include developing public understanding of weight loss 
(e.g., see Puhl & Heuer, 2010) and tailoring information to those at high-risk of developing 
EDs (e.g., individuals engaging in extreme dieting). 
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At present, there is insufficient evidence to conclude that WS is a strong predictor of 
outcomes other than weight change.  Further work in this area may be warranted, but we also 
suggest that authors consider the role of WS as a predictor and/or as a moderator of outcome.  
Similarly, further research might consider whether there is a level of WS above which 
treatment outcomes are significantly impacted.  We recommend that future studies provide 
sufficient information to enable detailed secondary (e.g., meta-) analysis, such as providing a 
scale-bound measure of fit (e.g., R2) in studies looking at the relation between WS and a 
given outcome.  If regression analyses are reported, we advise including both standardised 
and unstandardized regression coefficients (slopes) with their respective standard errors and 
sample sizes (e.g., see Berner et al., 2013).  In addition, mean (SD) values for different 
groups (e.g., WS in completers versus non-completers) would also be of use.  Although the 
regression coefficient is equivalent to Pearson’s r in a simple regression (Hayes, 2013), more 
information may be needed in hierarchical models.  Finally, as many studies report data from 
secondary analysis of treatment studies, it would be advisable to ensure that studies have 
sufficient power to correctly interpret model estimates.  Although meta-analysis was not 
performed, we hope that the summary of findings presented here might help in this regard. 
In summary, WS represents a variable that has shown some promise in predicting 
weight change over the course of psychological treatment.  However, more work in this area 
is needed to establish whether WS predicts outcomes more generally, whether a moderator 
effect exists, and if there is a WS threshold beyond which outcomes are consistently affected. 
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Table 1.  Studies included in the review. 
 Pre-treatment study characteristics Outcome 
First author, 
year 
N (% 
female) 
Mean 
age, y 
(SD) 
Age 
range, 
y 
Weight 
status 
Mean 
BMI, 
kg/m2 
Treatment Mean 
WS, kg 
(SD) 
Definition of 
abstinence 
Abstinence Weight 
gain 
Treatment 
completion 
Berner, 2013 
 
 
350 
(100) 
23.9 
(10.0) 
NR Underweight 15.7 Inpatient 15.82 
(9.18) 
NA 
NR NR + 
Butryn, 2006 
(see Agras et 
al., 2000, for 
details) 
 
 
188 
(100) 
28.1 
(7.9) 
NR Normal 23.5 CBT-BN 9.4 
(9.5) 
No binge eating 
or purging, 
assessed through 
EDE (covering a 
4-week period) 
+ NR + 
Carter, 2008 
(see Bulik et 
al., 1998, for 
details) 
 
 
 
 
135 
(100) 
26.1 
(6.1) 
17 – 
45 
Normal 22.5 CBT + BT 7.1 
(7.4) 
No binge eating 
or purging, 
assessed through 
structured 
interview 
(covering a 2-
week period) 
/ + / 
Carter,2015 
(see 
McIntosh et 
al., 2005, for 
details) 
 
35 
(100) 
24.3 
(6.8) 
16 – 
40 
Underweight 17.4 CBT, IPT, 
or SSCM 
14.3 
(7.8) 
No binge eating 
or purging, 
assessed through 
EDE (covering a 
4-week period) 
+ / / 
Dawkins, 
2013 
 
117 
(100) 
25.5 
(7.6) 
16 – 
NR 
Normal 22.6 CBT-E 9.5 
(11.9) 
No binge eating 
or purging from / NR / 
28 
 
 
 
 
EDE-Q (i.e., 4 
weeks) 
Hessler, 
2017 
 
 
179 
(100) 
26.6 
(8.9) 
18 – 
55 
Normal 22.0 Inpatient NR NA 
+ NR NR 
Lowe, 2006 
 
 
146 
(100) 
25.4 
(7.9) 
14 – 
53 
Normal 23.2 Inpatient 12 
(NR) 
NA 
NR + NR 
Seetharaman, 
2017 
 
163 
(100) 
16.6 
(2.1) 
12 – 
18 
Underweight NR Outpatient NR NA 
NR NR NR 
Wildes, 2012 
 
 
 
 
 
 
185 
(97.3) 
27.0 
(10.2) 
16 – 
NR 
Underweight 15.7 Inpatient 
and 
Daypatient 
17.1 
(10.8) 
No binge eating 
or purging, 
assessed through 
modified EDE 
(covering a 4-
week period) 
+ / + 
Zunker, 2011 
(see Peterson 
et al., 2009, 
for details) 
 
 
259 
(87.6) 
47.1 
(10.4) 
19 – 
65 
Normal 39.0 Group 
CBT 
Median 
= 2.27 
No binge eating 
or purging, 
assessed through 
EDE (covering a 
4-week period) 
/ / / 
Zunker, 2011 
(see Mitchell 
et al., 2008, 
for details) 
 
128 
(98.4) 
29.0 
(10.7) 
18 – 
60 
Normal 23.4 CBT-BN 9.2 
(12.1) 
No binge eating 
or purging, 
assessed through 
EDE (covering a 
4-week period) 
/ / / 
29 
 
Abbreviations: AN = anorexia nervosa; BMI = body mass index; BN = bulimia nervosa; BT = behavior therapy; CBT = cognitive behavior 
therapy; EDE = Eating Disorder Examination; EDE-Q = Eating Disorder Examination – Questionnaire; IPT = interpersonal psychotherapy; M = 
mean; SSCM = specialist supportive clinical management; WS = weight suppression; NA = not applicable; NR = not reported; + = predicted; / = 
not predicted 
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Figure 1.  PRISMA flow diagram 
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